Clinically meaningful biomarkers for psychosis: A systematic and quantitative review
Diana Prata, Andrea Mechelli, Shitij Kapur
Neuroscience & Biobehavioral Reviews | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2014
Awarded by National Institute for Health Research (NIHR)
Awarded by Medical Research Council (MRC)
Awarded by Medical Research Council
Awarded by National Institute for Health Research
This research was supported by a National Institute for Health Research (NIHR) fellowship (NIHR-PDF-2010-03-047) to DP and a grant (99859) from the Medical Research Council (MRC) to AM and SK. SK receives also funding from the NIHR Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. SK has served as ad-hoc consultant and/or speaker for AstraZeneca, Bioline, Bristol Meyers Squibb, Eli Lilly, Envivo, Janssen - Johnson and Johnson, NeuroSearch, Otsuka, Pfizer, Roche, Sanofi-Aventis, Schering-Plough, Servier, Solvay Wyeth and serves on the Scientific Advisory Boards for Lundbeck and Roche. DP and AM report no competing or financial relationships with commercial interests during the past 3 years. DP had full access to all the data and takes responsibility for its integrity and the accuracy of the data analysis. All authors contributed significantly either to conception and design (SK, DP, AM) or analysis (DP, AM) and interpretation of data (SK, DP, AM), and to drafting (DP) or revising (SK, DP, AM) and final approval (SK, DP, AM) of the article. DP had access to all reported and unreported data from the study as well as complete freedom to direct its analysis and reporting, without influence or censorship from sponsors. Three files of supplemental data as Supplemental material are provided.